- Conditions
- Enteric Hyperoxaluria, Hyperoxaluria
- Interventions
- C-13 labeled oxalate
- Drug
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 4 Years and older
- Enrollment
- 114 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1998 – 2020
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
Source: ClinicalTrials.gov public record
Updated Mar 2, 2020 · Synced May 21, 2026, 10:00 PM EDT